Influence of Trigger PSA and PSA Kinetics on 11C-Choline PET/CT Detection Rate in Patients with Biochemical Relapse After Radical Prostatectomy-Reference-Cited by-同舟云学术

Influence of Trigger PSA and PSA Kinetics on 11C-Choline PET/CT Detection Rate in Patients with Biochemical Relapse After Radical Prostatectomy

Published:2009-08-18 Issue:9 Volume:50 Page:1394-1400
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Castellucci Paolo,Fuccio Chiara,Nanni Cristina,Santi Ivan,Rizzello Anna,Lodi Filippo,Franceschelli Alessandro,Martorana Giuseppe,Manferrari Fabio,Fanti Stefano

Publisher

Society of Nuclear Medicine

Subject

Radiology, Nuclear Medicine and imaging

Reference36 articles.

1. ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of prostate cancer

2. Time trends in biochemical recurrence after radical prostatectomy: results of the SEARCH database

3. Biochemical (Prostate Specific Antigen) Recurrence Probability Following Radical Prostatectomy for Clinically Localized Prostate Cancer

4. A comparison of the single and double factor high-risk models for risk assignment of prostate cancer treated with 3D conformal radiotherapy

5. PSA Doubling Time as a Predictor of Clinical Progression After Biochemical Failure Following Radical Prostatectomy for Prostate Cancer

Cited by 217 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PET and radionuclides in prostate cancer;Revisiones en Cáncer;2024

2. Les radiotraceurs autres que le PSMA-ligand pour l’imagerie TEP du cancer de prostate;Médecine Nucléaire;2023-10

3. Head-to-Head Comparison of [18F]F-choline and Imaging of Prostate-Specific Membrane Antigen, Using [18F]DCFPyL PET/CT, in Patients with Biochemical Recurrence of Prostate Cancer;Current Oncology;2023-06-30

4. ACR Appropriateness Criteria® Post-Treatment Follow-up of Prostate Cancer: 2022 Update;Journal of the American College of Radiology;2023-05

5. Comparison of Hormone-Sensitive Oligorecurrent Prostate Cancer Patients Based on Routine Use of Choline and/or PSMA PET/CT to Guide Metastasis-Directed Therapy;Cancers;2023-03-22